Alison Redding
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $945.74 | 49 | 97.6% |
| Education | $23.32 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $220.81 | 13 | $0 (2024) |
| ABBVIE INC. | $87.99 | 4 | $0 (2024) |
| Inspire Medical Systems, Inc. | $72.03 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $61.79 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $57.94 | 3 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $49.42 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $46.94 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $40.55 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.80 | 2 | $0 (2023) |
| Lilly USA, LLC | $35.99 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.39 | 23 | Novo Nordisk Inc ($117.95) |
| 2023 | $473.53 | 26 | Novo Nordisk Inc ($102.86) |
| 2022 | $17.14 | 1 | Janssen Pharmaceuticals, Inc ($17.14) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.29 | General |
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.63 | General |
| 08/29/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
| 07/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.11 | General |
| 07/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: UROLOGY | ||||||
| 07/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $72.03 | General |
| Category: NEUROLOGY | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: UROLOGY | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.89 | General |
| 04/11/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Bone Health | ||||||
| 02/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: PSYCHIATRY | ||||||
| 02/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $23.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,214 | 1,928 | $146,265 | $68,964 |
| 2022 | 1 | 11 | 14 | $2,030 | $1,307 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 343 | $49,735 | $29,883 | 60.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $7,150 | $6,195 | 86.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $9,660 | $3,794 | 39.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $4,785 | $3,401 | 71.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 65 | 84 | $8,400 | $2,437 | 29.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 115 | 283 | $4,245 | $2,377 | 56.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 29 | $2,175 | $2,083 | 95.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 32 | $3,200 | $2,023 | 63.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $3,075 | $1,934 | 62.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $2,460 | $1,765 | 71.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $1,980 | $1,656 | 83.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 108 | 158 | $10,270 | $1,635 | 15.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 90 | 104 | $6,760 | $1,364 | 20.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 65 | 82 | $4,920 | $1,350 | 27.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 93 | 145 | $5,075 | $1,103 | 21.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 60 | 70 | $4,550 | $1,035 | 22.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 87 | 108 | $4,320 | $1,028 | 23.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 30 | $1,185 | $837.95 | 70.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 52 | 95 | $4,465 | $787.55 | 17.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $830.00 | $623.85 | 75.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 60 | $2,700 | $606.00 | 22.4% |
| 83735 | Magnesium level | Office | 2023 | 31 | 52 | $1,560 | $341.64 | 21.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 21 | 24 | $1,320 | $320.64 | 24.3% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 12 | 12 | $300.00 | $150.00 | 50.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 14 | 16 | $320.00 | $90.56 | 28.3% |
About Alison Redding
Alison Redding is a Student in an Organized Health Care Education/Training Program healthcare provider based in Laurel, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1205398245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alison Redding has received a total of $969.06 in payments from pharmaceutical and medical device companies, with $478.39 received in 2024. These payments were reported across 50 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($945.74).
As a Medicare-enrolled provider, Redding has provided services to 1,225 Medicare beneficiaries, totaling 1,942 services with total Medicare billing of $70,271. Data is available for 2 years (2022–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Laurel, MS
- Active Since 04/01/2019
- Last Updated 06/21/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1205398245
Products in Payments
- Rybelsus (Drug) $86.36
- INSPIRE (Device) $72.03
- REXULTI (Drug) $57.94
- GEMTESA (Drug) $49.42
- INJECTAFER (Drug) $46.94
- STEGLATRO (Drug) $41.45
- JARDIANCE (Drug) $36.80
- MOUNJARO (Drug) $35.99
- EVENITY (Biological) $32.31
- LEQVIO (Drug) $30.65
- GVOKE HYPOPEN (Drug) $29.80
- AVYCAZ (Drug) $27.25
- ZYMFENTRA (Biological) $23.32
- FARXIGA (Drug) $23.16
- FLOWTRIEVER CATHETER, S (Device) $21.84
- IBSRELA (Drug) $21.78
- DALVANCE (Drug) $20.89
- JANUVIA (Drug) $20.34
- TEFLARO (Drug) $20.05
- QULIPTA (Drug) $19.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Laurel
Seth Ladd, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $16,591
Logan Kolakowski, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $7,204
Dr. Sarah Queck, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,711
Scott Kim, Dmd, Md, DMD, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,708
Alla Yugay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1,223
Monika Thoppil, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $904.23